FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
POLYMED
307
-0.55 (-0.18%)
Updated 03:29 06/07 IST
POLYMED Buy or Sell - FrontPage Forums
0 Users have submitted 0 trade ideas of Rs. 0 for POLYMED
Disclaimer0% Bullish
0% Bearish
POLYMED Buy or Sell - Brokerage Reports
No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
POLYMED Ratings
Long term POLYMED rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
0/5 (0 Ratings)0
Find answers to all your questions on live POLYMED message board: Is POLYMED buy or sell? Should I buy POLYMED shares? Why are POLYMED shares falling? Should I invest in POLYMED stock?
- Home
- POLYMED Forum
POLYMED Share Price Discussion
N
Reputation: 3,388 • Jun 8 4:18 AM
Poly Medicure Consolidated March 2020 Net Sales at Rs 171.33 crore, down 0.52% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 3,388 • Jun 8 4:13 AM
Poly Medicure Standalone March 2020 Net Sales at Rs 159.18 crore, down 0.43% Y-o-Y
Moneycontrol
Like
Reply
F
Reputation: 32 • Jun 1 8:43 AM
Medical device industry to get over ₹3,000 crore boost
Financial incentives on anvil to boost local manufacturing of medical devices over five years
Financial incentives on anvil to boost local manufacturing of medical devices over five years
@businessline
Like
Reply
K
Reputation: 16 • Apr 12 2:39 AM
Q. Will hit the 320 target again ?
Will hit the 320 target again ?
Like
Reply (1)
Latest replies
241 to 285 range ...if breaks 285 will hit 320
N
Reputation: 3,388 • Feb 20 4:18 AM
Nifty's Island Reversal pattern indicates bulls may take charge again
The setup indicates that the bulls could take the rally towards 12,239 but the pace is likely to be de-accelerated.
The setup indicates that the bulls could take the rally towards 12,239 but the pace is likely to be de-accelerated.
Moneycontrol
Like
Reply
A
Reputation: 464 • Feb 9 4:00 AM
Great earnings and strong price performance are a powerful combination that make this a stock to evaluate closely.
Poly Medicure Lt is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 508.44 Cr. and Eq...
Read more...
Like
Reply
M
Reputation: 0 • Sep 10, 2019 9:58 AM
Is there any hope the price of this share will increase in the near future.
Like
Reply
N
Reputation: 3,388 • Aug 13, 2019 7:23 AM
Poly Medicure Standalone June 2019 Net Sales at Rs 152.36 crore, up 15.98% Y-o-Y
moneycontrol.com
Like
Reply
N
Reputation: 3,388 • Jul 25, 2019 3:33 AM
Ashish Kacholia raises stake in 6 companies, keeps it constant in 13
Like
Reply
N
Reputation: 3,388 • Jan 25, 2019 9:27 AM
Poly Medicure Standalone December 2018 Net Sales at Rs 148.70 crore, up 18.26% Y-o-Y
Like
Reply
N
Reputation: 3,388 • Oct 29, 2018 12:37 PM
Poly Medicure Standalone September 2018 Net Sales at Rs 146.75 crore, up 8.76% Q-o-Q
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
POLYMED Share Price - Technicals
- NewsBotJun 8 4:18 AMPoly Medicure Consolidated March 2020 Net Sales at Rs 171.33 crore, down 0.52% Y-o-YMoneycontrolNewsBotJun 8 4:13 AMPoly Medicure Standalone March 2020 Net Sales at Rs 159.18 crore, down 0.43% Y-o-YMoneycontrolNewsBotFeb 20 4:18 AMNifty's Island Reversal pattern indicates bulls may take charge againMoneycontrolNewsBotAug 13, 2019 7:23 AMPoly Medicure Standalone June 2019 Net Sales at Rs 152.36 crore, up 15.98% Y-o-Ymoneycontrol.comNewsBotJul 25, 2019 3:33 AMAshish Kacholia raises stake in 6 companies, keeps it constant in 13NewsBotJan 25, 2019 9:27 AMPoly Medicure Standalone December 2018 Net Sales at Rs 148.70 crore, up 18.26% Y-o-YNewsBotOct 29, 2018 12:37 PMPoly Medicure Standalone September 2018 Net Sales at Rs 146.75 crore, up 8.76% Q-o-Q
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.